XIAOMI-W
01810
TRIP.COM-S
09961
JD HEALTH
06618
BILIBILI-W
09626
JD-SW
09618
(Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -50.92%86.41M | ---- | 12.47%176.06M | ---- | -48.93%156.54M | ---- | 50.06%306.54M | ---- | -34.35%204.28M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -58.78%-155.65M | ---- | -37.01%-98.03M | ---- | 35.75%-71.55M | ---- | 26.99%-111.36M | ---- | 1.68%-152.54M |
Dividend (income)- adjustment | ---- | -49.42%-3.47M | ---- | 11.74%-2.32M | ---- | -113.46%-2.63M | ---- | 39.50%-1.23M | ---- | 3.96%-2.04M |
Impairment and provisions: | ---- | 27.69%130.95M | ---- | -39.89%102.55M | ---- | 133.37%170.6M | ---- | -31.34%73.1M | ---- | 200.23%106.48M |
-Impairment of trade receivables (reversal) | ---- | 39.64%128.59M | ---- | -29.20%92.09M | ---- | 133.52%130.08M | ---- | -49.78%55.7M | ---- | 452.19%110.91M |
-Other impairments and provisions | ---- | -77.43%2.36M | ---- | -74.18%10.46M | ---- | 132.90%40.52M | ---- | 492.60%17.4M | ---- | -128.82%-4.43M |
Revaluation surplus: | ---- | 70.86%117.52M | ---- | 147.48%68.78M | ---- | -25.46%27.79M | ---- | -64.74%37.29M | ---- | 29,442.18%105.76M |
-Fair value of investment properties (increase) | ---- | 14.76%54M | ---- | 119.30%47.06M | ---- | -28.70%21.46M | ---- | -65.23%30.09M | ---- | 910.01%86.56M |
-Other fair value changes | ---- | 192.34%63.52M | ---- | 242.89%21.73M | ---- | -11.94%6.34M | ---- | -62.53%7.2M | ---- | 73.88%19.2M |
Asset sale loss (gain): | ---- | -221.99%-8.23M | ---- | 185.12%6.75M | ---- | -11.68%-7.93M | ---- | -282.02%-7.1M | ---- | 1,566.24%3.9M |
-Loss (gain) from sale of subsidiary company | ---- | -92.44%732K | ---- | --9.69M | ---- | ---- | ---- | ---- | ---- | ---2.18M |
-Loss (gain) on sale of property, machinery and equipment | ---- | -3,191.34%-7.6M | ---- | 75.68%-231K | ---- | ---950K | ---- | ---- | ---- | ---40K |
-Loss (gain) from selling other assets | ---- | 49.78%-1.36M | ---- | 61.18%-2.71M | ---- | 1.70%-6.98M | ---- | -215.96%-7.1M | ---- | 2,515.38%6.12M |
Depreciation and amortization: | ---- | 1.43%23.7M | ---- | -2.19%23.37M | ---- | 28.06%23.89M | ---- | 134.43%18.66M | ---- | 3.54%7.96M |
-Depreciation | ---- | 1.43%23.7M | ---- | -2.19%23.37M | ---- | 28.06%23.89M | ---- | --18.66M | ---- | ---- |
-Other depreciation and amortization | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 3.54%7.96M |
Financial expense | ---- | -49.58%1.68M | ---- | 90.53%3.34M | ---- | -64.61%1.75M | ---- | -84.65%4.95M | ---- | -66.86%32.27M |
Special items | ---- | ---- | ---- | -10,426.57%-27.99M | ---- | 40.41%271K | ---- | -61.78%193K | ---- | -98.94%505K |
Operating profit before the change of operating capital | ---- | -23.60%192.92M | ---- | -15.47%252.52M | ---- | -6.95%298.74M | ---- | 4.72%321.05M | ---- | -10.54%306.57M |
Change of operating capital | ||||||||||
Accounts receivable (increase)decrease | ---- | -86.85%86.14M | ---- | -6.23%655.1M | ---- | 774.90%698.61M | ---- | -430.22%-103.51M | ---- | -91.96%31.35M |
Accounts payable increase (decrease) | ---- | 37.38%-102.44M | ---- | 8.32%-163.59M | ---- | -188.04%-178.44M | ---- | 128.03%202.68M | ---- | -204.44%-722.97M |
prepayments (increase)decrease | ---- | 726.16%23.58M | ---- | -125.22%-3.77M | ---- | 30.70%14.93M | ---- | 132.23%11.42M | ---- | -523.97%-35.45M |
Special items for working capital changes | ---- | ---- | ---- | ---- | ---- | 855.06%236.4M | ---- | -102.85%-31.31M | ---- | 196.93%1.1B |
Cash from business operations | ---- | -71.53%263.75M | ---- | -13.44%926.4M | ---- | 167.34%1.07B | ---- | -40.80%400.32M | ---- | 101.27%676.2M |
Hong Kong profits tax paid | ---- | 67.78%-8.15M | ---- | 69.82%-25.28M | ---- | -118.72%-83.77M | ---- | 42.43%-38.3M | ---- | 23.73%-66.53M |
Other taxs | ---- | -84.20%-3.08M | ---- | 6.18%-1.67M | ---- | -102.16%-1.78M | ---- | 57.13%-881K | ---- | -42.61%-2.06M |
Interest received - operating | ---- | 57.49%156.38M | ---- | 49.50%99.29M | ---- | -39.60%66.42M | ---- | -31.66%109.96M | ---- | 4.96%160.9M |
Interest paid - operating | ---- | 37.50%-55K | ---- | 27.27%-88K | ---- | 93.38%-121K | ---- | ---1.83M | ---- | ---- |
Special items of business | -40.04%210.39M | ---- | 126.09%350.9M | ---- | -82.54%155.2M | ---- | 474.86%889.11M | ---- | -645.50%-237.18M | ---- |
Net cash from operations | -40.04%210.39M | -59.06%408.85M | 126.09%350.9M | -4.98%998.65M | -82.54%155.2M | 123.96%1.05B | 474.86%889.11M | -38.94%469.27M | -645.50%-237.18M | 91.85%768.52M |
Cash flow from investment activities | ||||||||||
Dividend received - investment | ---- | 49.42%3.47M | ---- | -11.74%2.32M | ---- | 113.46%2.63M | ---- | -39.50%1.23M | ---- | -3.96%2.04M |
Sale of fixed assets | ---- | 3,191.34%7.6M | ---- | -75.68%231K | ---- | --950K | ---- | ---- | ---- | 37.93%40K |
Purchase of fixed assets | ---- | 57.59%-3.09M | ---- | 38.41%-7.29M | ---- | 58.10%-11.84M | ---- | -3,324.61%-28.25M | ---- | 9.64%-825K |
Selling intangible assets | ---- | --2M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Purchase of intangible assets | ---- | ---- | ---- | ---2K | ---- | ---- | ---- | ---- | ---- | ---- |
Sale of subsidiaries | ---- | -95.10%14.5M | ---- | 134.83%295.88M | ---- | --126M | ---- | ---- | ---- | --61.43M |
Acquisition of subsidiaries | ---- | ---11.88M | ---- | ---- | ---- | ---- | ---- | -592.35%-525.44M | ---- | -89.73%-75.89M |
Recovery of cash from investments | ---- | -31.87%64.2M | ---- | -10.41%94.24M | ---- | 4.03%105.18M | ---- | -66.30%101.11M | ---- | 100.00%300M |
Cash on investment | ---- | 85.85%-61.55M | ---- | -210.81%-434.83M | ---- | 7.67%-139.9M | ---- | -42.21%-151.53M | ---- | -7.32%-106.55M |
Other items in the investment business | -318.17%-200.09M | 40.46%-23.71M | -123.17%-47.85M | -144.69%-39.83M | 328.11%206.54M | 612.76%89.12M | 84.91%-90.55M | 167.88%12.5M | -603.50%-599.95M | 85.68%-18.42M |
Net cash from investment operations | -318.17%-200.09M | 90.54%-8.45M | -123.17%-47.85M | -151.86%-89.28M | 328.11%206.54M | 129.16%172.14M | 84.91%-90.55M | -464.84%-590.38M | -603.50%-599.95M | 238.66%161.82M |
Net cash before financing | -96.60%10.3M | -55.97%400.4M | -16.23%303.05M | -25.65%909.37M | -54.70%361.75M | 1,109.96%1.22B | 195.39%798.56M | -113.02%-121.11M | -1,058.47%-837.14M | 227.72%930.34M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | ---- | ---- | ---- | ---- | -91.97%649.61M | ---- | 2,427.12%8.09B | ---- | -19.36%320M |
Refund | ---- | -1,587.39%-89.26M | ---- | 99.05%-5.29M | ---- | 93.14%-555.06M | ---- | -2,085.62%-8.09B | ---- | 9.05%-370M |
Interest paid - financing | ---- | 49.91%-1.63M | ---- | -101.74%-3.25M | ---- | 47.97%-1.61M | ---- | 16.85%-3.1M | ---- | 55.79%-3.73M |
Dividends paid - financing | ---- | 0.00%-137.15M | ---- | -0.00%-137.15M | ---- | -13.60%-137.15M | ---- | 44.20%-120.73M | ---- | 12.17%-216.37M |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%-262.5M |
Other items of the financing business | 57.00%-68.57M | ---- | -118.83%-159.47M | ---- | -357.74%-72.87M | ---- | -93.13%28.27M | ---- | 317.51%411.39M | ---170K |
Net cash from financing operations | 57.00%-68.57M | -56.12%-228.04M | -118.83%-159.47M | -221.82%-146.07M | -357.74%-72.87M | 63.57%-45.39M | -93.13%28.27M | 76.62%-124.58M | 317.51%411.39M | -1.04%-532.77M |
Effect of rate | 150.00%415K | 201.00%203K | 181.37%166K | 85.86%-201K | 3.77%-204K | -147.30%-1.42M | -1,160.00%-212K | -133.24%-575K | -78.02%20K | 1,980.43%1.73M |
Net Cash | -140.59%-58.28M | -77.42%172.37M | -50.30%143.58M | -35.19%763.31M | -65.06%288.88M | 579.37%1.18B | 294.21%826.84M | -161.80%-245.69M | -318.23%-425.75M | 263.35%397.57M |
Begining period cash | 6.64%2.77B | 41.58%2.6B | 41.58%2.6B | 178.53%1.84B | 178.52%1.84B | -27.21%658.91M | -27.21%658.91M | 78.93%905.18M | 78.93%905.18M | -32.49%505.87M |
Cash at the end | -1.06%2.71B | 6.64%2.77B | 29.11%2.74B | 41.58%2.6B | 42.97%2.12B | 178.53%1.84B | 209.84%1.49B | -27.21%658.91M | 18.63%479.45M | 78.93%905.18M |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.